Immunotherapy is the new black when it comes to treating Cancer, raising hope in conquering this age old illness.
Editor’s Note June 5, 2012
This week, we respond to a recent Wall Street Journal article documenting immunotherapy as a new treatment for Cancer. We tell you what companies they missed. OneMedRadio brings you management interviews with […]
Four Cancer Therapies to Watch
On June 1, more than 25,000 cancer specialists will come together at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. With ASCO hours away, we look at some small biotech companies making headway in cancer treatment.
Biovest Seeking Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
OneMedRadio: NanoViricides CEO Discusses U.S. Patent
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
Editor’s Note May 22, 2012
This week, OneMedRadio brings you two management interviews. Iconic Data, CEO David LaBorde discusses their lead product SwiftPayMD and why it is changing the face of patient billing. Opexa CEO, Neil Warma […]
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
The Technology Corner: Disruptive Technology for Prostate Cancer
In this special series we present emerging technologies which hold the promise to significantly improve the prognosis of patients diagnosed with prostate cancer, and cancer in general.
